<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Platelet-fibrin <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> in the lumen of atherostenotic carotid arteries may underlie <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> and <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>For this reason, we investigated the antiplatelet and antithrombotic effects of a novel and potent platelet fibrinogen receptor (<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> IIb/IIIa) <z:chebi fb="68" ids="48706">antagonist</z:chebi> (SK&amp;F 106760) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The effects of 0.1-3.0 mg/kg i.v </plain></SENT>
<SENT sid="3" pm="."><plain>SK&amp;F 106760 on platelet aggregation were examined ex vivo in canine platelet-rich plasma (n = 20) </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, the antithrombotic effects of SK&amp;F 106760 were compared with those of aspirin in an <z:hpo ids='HP_0011009'>acute</z:hpo> canine model of extracranial carotid artery <z:mp ids='MP_0005048'>thrombosis</z:mp> with high-grade stenosis </plain></SENT>
<SENT sid="5" pm="."><plain>Sham-operated (n = 4), vehicle-treated (n = 6), SK&amp;F 106760-treated (n = 8), aspirin-treated (n = 9), and SK&amp;F 106760+aspirin-treated (n = 5) dogs were examined </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The intravenous administration of SK&amp;F 106760 caused a dose-related inhibition of ex vivo platelet aggregation </plain></SENT>
<SENT sid="7" pm="."><plain>In the carotid artery <z:mp ids='MP_0005048'>thrombosis</z:mp> model, an occlusive <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formed at stenotic sites in the region of the carotid bifurcation </plain></SENT>
<SENT sid="8" pm="."><plain>The thrombogenic process caused a progressive reduction in carotid blood flow and reduced the cortical microvascular perfusion and electroencephalographic power </plain></SENT>
<SENT sid="9" pm="."><plain>Based on nuclear magnetic resonance spectroscopy, the occlusive events depleted the stores of high-energy phosphates (<z:chebi fb="3" ids="15422">adenosine triphosphate</z:chebi> and phosphocreatine) and increased the <z:chebi fb="4" ids="24996">lactate</z:chebi> concentration in the forelimb somatosensory area of the parietal cortex </plain></SENT>
<SENT sid="10" pm="."><plain>In this model, the administration of 1 mg/kg i.v </plain></SENT>
<SENT sid="11" pm="."><plain>SK&amp;F 106760 prevented <z:mp ids='MP_0005048'>thrombosis</z:mp> of the stenotic carotid artery </plain></SENT>
<SENT sid="12" pm="."><plain>Consequently, neurophysiological, cerebral hemodynamic, and metabolic parameters were <z:hpo ids='HP_0000001'>all</z:hpo> improved significantly in the SK&amp;F 106760-treated group </plain></SENT>
<SENT sid="13" pm="."><plain>No dog receiving SK&amp;F 106760 reoccluded during the 1-hour posttreatment observation period </plain></SENT>
<SENT sid="14" pm="."><plain>In contrast, <z:mp ids='MP_0005048'>thrombosis</z:mp> of the carotid artery was associated with neurophysiological deterioration in six of the nine dogs treated with 5 mg/kg i.v. aspirin </plain></SENT>
<SENT sid="15" pm="."><plain>Both spontaneous and evoked (increased <z:hpo ids='HP_0100546'>carotid stenosis</z:hpo>) aspirin-resistant <z:mp ids='MP_0005048'>thrombosis</z:mp> were abolished by SK&amp;F 106760 treatment </plain></SENT>
<SENT sid="16" pm="."><plain>CONCLUSIONS: These results suggest that antagonism of fibrinogen binding to platelet <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> IIb/IIIa (the final common pathway for aggregation) may represent a new and more effective antithrombotic approach to the treatment of cerebral <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> and infarction associated with extracranial <z:e sem="disease" ids="C0007273" disease_type="Disease or Syndrome" abbrv="">carotid artery disease</z:e> </plain></SENT>
</text></document>